SCHEMBL10733119

SCHEMBL10733119

CCN(CC)c1ccccc1-c1nc2cnncc2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.41
▸ ALDH1A1 P00352 7/20 0.41
▸ RAB9A P51151 6/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ NPSR1 Q6W5P4 3/20 0.41
▸ HTT P42858 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ CYP1A2 P05177 4/20 0.40
▸ CYP2C19 P33261 4/20 0.40
▸ PDE5A O76074 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ CYP2D6 P10635 3/20 0.40
▸ PTGES O14684 1/20 0.39
▸ KDM4E B2RXH2 6/20 0.39
▸ MAPT P10636 4/20 0.39
▸ GAA P10253 2/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10741664 0.85 PTGES (0.52) NPC1ALDH1A1RAB9ASMN1; SMN2NPSR1
SCHEMBL10739495 0.76 NPC1 (0.49) NPC1ALDH1A1RAB9ASMN1; SMN2NPSR1
SCHEMBL10743785 0.76 PDE5A (0.60) ALDH1A1HPGDPDE5AKDM4EUSP2
SCHEMBL7553973 0.75 PDE5A (0.53) NPC1ALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL7158379 0.75 PDE5A (0.42) NPC1ALDH1A1RAB9ASMN1; SMN2NPSR1
SCHEMBL3799818 0.74 NPC1 (0.68) NPC1ALDH1A1RAB9ASMN1; SMN2NPSR1
SCHEMBL10740903 0.74 NPC1 (0.42) NPC1ALDH1A1RAB9ASMN1; SMN2NPSR1
SCHEMBL10740825 0.74 F7 (0.55) NPC1ALDH1A1RAB9ASMN1; SMN2NPSR1
SCHEMBL7546955 0.74 NPC1 (0.51) NPC1ALDH1A1RAB9ASMN1; SMN2NPSR1
SCHEMBL10740756 0.74 PDE5A (0.62) ALDH1A1SMN1; SMN2HPGDCYP1A2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback